Table 3.
Comparisons of total WOMAC score (primary end point).
| GMGHT group (n= 61) | Placebo group (n= 66) | p value | |
|---|---|---|---|
| Total WOMAC score | |||
| Baseline (day =0) | 55.8 (13.0) | 54.1 (13.9) | 0.48 |
| 2nd week | 45.5 (14.9) | 51.6 (14.0) | 0.20 |
| 4th week | 37.5(18.2) | 50.0 (13.7) | 3.07 x 10−5 |
| 6th week | 34.7 (18.1) | 46.9 (14.5) | 5.53 x 10−5 |
| Change in total WOMAC score from baseline | |||
| 2nd week | -10.3 (11.2) | -2.5 (4.6) | 2.93 x 10−6 |
| 4th week | -18.3 (16.9) | -4.1 (5.2) | 2.38 x 10−8 |
| 6th week | -21.1 (17.5) | -7.1 (8.1) | 1.85 x 10−7 |
Values are presented as mean (SD) unless otherwise stated.
GMGHT: Gumiganghwal-tang, SD: standard deviation, WOMAC: the Western Ontario and McMaster Universities Arthritis Index.